DIABETES PREVENTION / RISK / OMICS / METABOLISM / THERAPY (PROMT) INTERDISCIPLINARY TRAINING
糖尿病预防/风险/组学/代谢/治疗(PROMT)跨学科培训
基本信息
- 批准号:10627642
- 负责人:
- 金额:$ 7.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-01 至 2028-03-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
PROJECT SUMMARY/ABSTRACT
Within the US, the incidence of diabetes is at epidemic proportions. At the same time, technological
advancements are offering promising strategies to therapeutically ameliorate diabetes. The Arthur Riggs
Diabetes & Metabolism Research Institute (AR-DMRI) at City of Hope (COH) is uniquely poised as a center of
translational research excellence with a long-standing record of success in diabetes research. As such, the COH
AR-DMRI has a profound commitment to training a diverse next generation of scientific leaders with the skills
needed to develop novel technologies and translate them into the clinic. The internationally recognized experts
Drs. Debbie Thurmond and Rama Natarajan formalized this commitment by bringing together research mentors
from 3 themes: Prevention/Risk/Biomarkers/Omics, Metabolism, and Diabetes Therapy to create the (PROMT)
Predoctoral T32 Training Program. The goal of the T32 program is to support outstanding predoctoral students
with analytically intensive science education from diverse backgrounds with distinct perspectives to become
scientific leaders in diabetes research in line with the NIDDK mission. The PROMT program will admit 2
predoctoral trainees/ year to participate in research across the translational science pipeline. PROMT will provide
an unprecedented experience for predoctoral trainees and is predicted to strengthen their commitment to
research careers that drive real change in clinical practice. Eligible candidates will be recruited through the Irell
& Manella Graduate School of Biological Sciences (IMGS) at COH. After 2 years of IMGS core curriculum,
PROMT students will commit to engage in PhD dissertation research and T32 program activities for 2 years. A
3rd year of PROMT training is available by competitive renewal. Trainees will select from among 16 Mentors and
17 Co-Mentors/Clinical Partners that comprise a collaborative group of faculties with a diverse array of interests
from basic, translational to clinical science. Research interests of the mentors include islet biology, epigenetics,
genomics and metabolomics, adipose and muscle metabolic dysregulation, and human islet transplantation,
among others. Program highlights include robust institutional support (Years 1 and 2) and unique research
resources on campus, including 3 GMP-compliant manufacturing facilities, and the Helford Clinical Research
Hospital. The AR-DMRI is home to the NIDDK-sponsored Integrated Islet Distribution Program (IIDP) and the
Human Islet Research Network (HIRN). The T32 curriculum focuses on diabetes and diabetes-related metabolic
diseases, with an emphasis on responsible research conduct and reproducibility. Laboratory research,
coursework, and translational research internships will be enhanced by regular institutional journal clubs,
seminars, and symposia, and a yearly PROMT retreat. The PROMT structure includes an Executive Committee,
Internal Advisory Board, External Advisory Board, Curriculum Committee, and Recruitment Committee. The AR-
DMRI is in a period of rapid growth, adding new departments and top-level faculty and state-of-the-art facilities,
and is pleased to welcome PROMT T32 students into our rigorous training environment.
项目总结/摘要
在美国,糖尿病的发病率处于流行病的比例。同时,技术
这些进展提供了治疗性改善糖尿病的有希望的策略。亚瑟·里格斯
City of Hope(COH)的糖尿病与代谢研究所(AR-DMRI)是一个独特的中心,
卓越的转化研究,在糖尿病研究方面有着长期的成功记录。因此,COH
AR-DMRI致力于培养具有以下技能的多元化下一代科学领导者
需要开发新的技术并将其应用于临床。国际公认的专家
Drs.黛比瑟蒙德和拉马纳塔拉詹通过将研究导师聚集在一起,将这一承诺正式化
从3个主题:预防/风险/生物标志物/组学,代谢和糖尿病治疗创建(PROMT)
博士前T32培训计划。T32计划的目标是支持优秀的博士前学生
来自不同背景的分析密集型科学教育,具有不同的视角,
与NIDDK使命一致的糖尿病研究的科学领导者。PROMT计划将承认2
博士前实习生/年参与整个转化科学管道的研究。PROMT将提供
一个前所未有的经验,为博士前学员,预计将加强他们的承诺,
推动临床实践发生真实的变化的研究职业。合格的候选人将通过Irell
& Manella Graduate School of Biological Sciences(IMGS)at COH.经过两年的IMGS核心课程,
PROMT学生将致力于从事博士论文研究和T32计划活动2年。一
PROMT培训的第三年可通过竞争性续约获得。学员将从16名导师中选出,
17名共同导师/临床合作伙伴,由具有不同兴趣的学院组成
从基础、转化到临床科学。导师的研究兴趣包括胰岛生物学,表观遗传学,
基因组学和代谢组学,脂肪和肌肉代谢失调,以及人类胰岛移植,
还有其他的该计划的亮点包括强大的机构支持(1年和2年)和独特的研究
校园资源,包括3个符合GMP的生产设施,以及赫尔福德临床研究
医院AR-DMRI是NIDDK赞助的综合胰岛分布计划(IIDP)和
人类胰岛研究网络(HIRN)。T32课程的重点是糖尿病和糖尿病相关的代谢
疾病,重点是负责任的研究行为和再现性。实验室研究,
课程和翻译研究实习将通过定期的机构期刊俱乐部得到加强,
研讨会和专题讨论会,以及每年的PROMT务虚会。PROMT的结构包括一个执行委员会,
内部顾问委员会、外部顾问委员会、课程委员会和招聘委员会。AR-
DMRI正处于快速发展时期,增加了新的部门和顶级教师和最先进的设施,
并很高兴地欢迎PROMT T32学生进入我们严格的培训环境。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RAMA NATARAJAN其他文献
RAMA NATARAJAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RAMA NATARAJAN', 18)}}的其他基金
Epigenetic Markers of Complications and Metabolic Memory in the DCCT/EDIC cohort.
DCCT/EDIC 队列中并发症和代谢记忆的表观遗传标记。
- 批准号:
8970574 - 财政年份:2015
- 资助金额:
$ 7.56万 - 项目类别:
Transcriptional Regulation by Angiotensin II in Vascular Smooth Muscle Cells
血管紧张素 II 在血管平滑肌细胞中的转录调节
- 批准号:
8206457 - 财政年份:2011
- 资助金额:
$ 7.56万 - 项目类别:
Transcriptional Regulation by Angiotensin II in Vascular Smooth Muscle Cells
血管紧张素 II 在血管平滑肌细胞中的转录调节
- 批准号:
8595327 - 财政年份:2011
- 资助金额:
$ 7.56万 - 项目类别:
Transcriptional Regulation by Angiotensin II in Vascular Smooth Muscle Cells
血管紧张素 II 在血管平滑肌细胞中的转录调节
- 批准号:
9262456 - 财政年份:2011
- 资助金额:
$ 7.56万 - 项目类别:
Transcriptional Regulation by Angiotensin II in Vascular Smooth Muscle Cells
血管紧张素 II 在血管平滑肌细胞中的转录调节
- 批准号:
8399013 - 财政年份:2011
- 资助金额:
$ 7.56万 - 项目类别:
Transcriptional Regulation by Angiotensin II in Vascular Smooth Muscle Cells
血管紧张素 II 在血管平滑肌细胞中的转录调节
- 批准号:
9406145 - 财政年份:2011
- 资助金额:
$ 7.56万 - 项目类别:
Transcriptional Regulation by Angiotensin II in Vascular Smooth Muscle Cells
血管紧张素 II 在血管平滑肌细胞中的转录调节
- 批准号:
8024654 - 财政年份:2011
- 资助金额:
$ 7.56万 - 项目类别:
Inflammatory Gene Regulation in Diabetic Conditions
糖尿病中的炎症基因调控
- 批准号:
8034544 - 财政年份:2010
- 资助金额:
$ 7.56万 - 项目类别:
Transforming growth factor beta1, microRNAs and diabetic nephropathy
转化生长因子β1、microRNA 和糖尿病肾病
- 批准号:
8772669 - 财政年份:2009
- 资助金额:
$ 7.56万 - 项目类别:
Transforming growth factor beta1, MicroRNAs and Diabetic Nephropathy
转化生长因子 beta1、MicroRNA 和糖尿病肾病
- 批准号:
7652597 - 财政年份:2009
- 资助金额:
$ 7.56万 - 项目类别:
相似国自然基金
一碳代谢(One carbon metabolism)介导上调的 PD1/PDL1 驱动
肿瘤免疫逃逸
- 批准号:2024JJ9491
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
相似海外基金
Effect of Acetylcholinesterase inhibitors on Bone Metabolism and Fracture Risk Factors among older adults with mild to moderate Alzheimer's Disease
乙酰胆碱酯酶抑制剂对患有轻至中度阿尔茨海默病的老年人骨代谢和骨折危险因素的影响
- 批准号:
10739853 - 财政年份:2023
- 资助金额:
$ 7.56万 - 项目类别:
Investigating the effects of APOE and APOE-related AD risk genes on human microglia activity and lipid metabolism in aging and disease
研究 APOE 和 APOE 相关 AD 风险基因对衰老和疾病过程中人类小胶质细胞活性和脂质代谢的影响
- 批准号:
10900992 - 财政年份:2023
- 资助金额:
$ 7.56万 - 项目类别:
Determine the molecular and metabolic mechanisms by which A-FABP links dysregulated lipid metabolism-induced obesity/breast cancer risk
确定 A-FABP 与脂质代谢失调引起的肥胖/乳腺癌风险相关的分子和代谢机制
- 批准号:
10683379 - 财政年份:2022
- 资助金额:
$ 7.56万 - 项目类别:
Lipoprotein Metabolism and Excess Cardiometabolic Risk in South Asians
南亚人的脂蛋白代谢和过度心脏代谢风险
- 批准号:
10705254 - 财政年份:2022
- 资助金额:
$ 7.56万 - 项目类别:
The effects of Alzheimer's disease risk genes on metabolism and signaling across cell types
阿尔茨海默病风险基因对跨细胞类型代谢和信号传导的影响
- 批准号:
10524301 - 财政年份:2022
- 资助金额:
$ 7.56万 - 项目类别:
Imaging Alterations in Endocannabinoid Metabolism in Clinical High Risk and First Episode Psychosis
临床高危和首发精神病中内源性大麻素代谢的影像学改变
- 批准号:
10707675 - 财政年份:2022
- 资助金额:
$ 7.56万 - 项目类别:
Lipoprotein Metabolism and Excess Cardiometabolic Risk in South Asians
南亚人的脂蛋白代谢和过度心脏代谢风险
- 批准号:
10539768 - 财政年份:2022
- 资助金额:
$ 7.56万 - 项目类别:
Development of an analysis system of systemic-cerebral circulatory metabolism for stroke risk prediction
开发用于脑卒中风险预测的全身-脑循环代谢分析系统
- 批准号:
22H00190 - 财政年份:2022
- 资助金额:
$ 7.56万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Determine the molecular and metabolic mechanisms by which A-FABP links dysregulated lipid metabolism-induced obesity/breast cancer risk
确定 A-FABP 与脂质代谢失调引起的肥胖/乳腺癌风险相关的分子和代谢机制
- 批准号:
10501614 - 财政年份:2022
- 资助金额:
$ 7.56万 - 项目类别:
Leveraging evolutionary genetics methods to understand the effects of rare variation in metabolism and improve polygenic risk score prediction
利用进化遗传学方法了解代谢中罕见变异的影响并改进多基因风险评分预测
- 批准号:
2889079 - 财政年份:2021
- 资助金额:
$ 7.56万 - 项目类别:
Studentship